PRESS RELEASE published on 01/23/2026 at 10:47, 5 months 3 days ago CTS EVENTIM: Ten-Year Naming Rights Partnership with Unipol – Arena Milano Renamed Unipol Dome Unipol partners with CTS EVENTIM to become naming rights sponsor of Milan's innovative arena, Unipol Dome, in a 10-year agreement from 2026-2035. The partnership includes image and technical collaborations Partnership CTS EVENTIM Naming Rights Milan Arena Unipol
BRIEF published on 12/03/2025 at 12:21, 6 months 23 days ago CTS EVENTIM dévoile l'ARENA MILANO avec l'icône du rock Ligabue Divertissement En Direct Arena Milano ÉVÉNEMENT CTS Performance De Ligabue Lieu En Italie
BRIEF published on 12/03/2025 at 12:21, 6 months 23 days ago CTS EVENTIM Unveils ARENA MILANO with Rock Icon Ligabue CTS EVENTIM Live Entertainment Arena Milano Ligabue Performance Italy Venue
PRESS RELEASE published on 12/03/2025 at 12:16, 6 months 23 days ago CTS EVENTIM: Italian rock superstar Ligabue will open the stage of the spectacular, brand new ARENA MILANO CTS EVENTIM Group to open Italy's largest indoor arena ARENA MILANO on 6 May 2026 with a performance by rock icon Ligabue, setting new standards in event infrastructure and premium experience Italy Live Entertainment CTS EVENTIM Group Indoor Arena Ligabue
BRIEF published on 11/20/2025 at 17:50, 7 months 5 days ago CTS EVENTIM réalise une croissance rentable dans un environnement difficile EBITDA Ajusté Divertissement En Direct Croissance Au Troisième Trimestre Segment De Billetterie ÉVÉNEMENT CTS
BRIEF published on 11/20/2025 at 17:50, 7 months 5 days ago CTS EVENTIM Achieves Profitable Growth in Challenging Environment Adjusted EBITDA CTS EVENTIM Live Entertainment Third Quarter Growth Ticketing Segment
PRESS RELEASE published on 11/20/2025 at 17:45, 7 months 5 days ago CTS EVENTIM: Profitable growth in the third quarter CTS EVENTIM reports profitable growth in Q3 2025, with adjusted EBITDA up by 13.8% and revenue by 3.5%. CEO emphasizes long-term value creation through technological advancements and acquisitions Adjusted EBITDA Revenue Profitable Growth CTS EVENTIM Q3 2025
BRIEF published on 11/20/2025 at 11:28, 7 months 6 days ago CTS EVENTIM Appoints William Willms as Chief Financial Officer Growth Strategy Chief Financial Officer CTS EVENTIM Live Entertainment William Willms
BRIEF published on 11/20/2025 at 11:28, 7 months 6 days ago CTS EVENTIM nomme William Willms au poste de directeur financier Stratégie De Croissance Directeur Financier Divertissement En Direct William Willms ÉVÉNEMENT CTS
PRESS RELEASE published on 11/20/2025 at 11:23, 7 months 6 days ago CTS EVENTIM appoints William Willms as new Chief Financial Officer CTS EVENTIM appoints William Willms as new Chief Financial Officer effective January 1, 2026. Willms brings extensive finance and transformation experience from Lufthansa Technik AG and Deutsche Lufthansa AG. His expertise will drive CTS EVENTIM's future growth Chief Financial Officer CTS EVENTIM Deutsche Lufthansa AG William Willms Lufthansa Technik AG
Published on 06/26/2026 at 14:05, 1 hour 23 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 28 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 28 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 43 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:17, 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/26/2026 at 15:17, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/26/2026 at 15:16, 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/26/2026 at 07:00, 8 hours 28 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 28 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel